期刊文献+

认知障碍患者173例的临床分析 被引量:1

Clinical analysis of 173 patients with cognitive impairment
原文传递
导出
摘要 目的比较不同程度认知障碍患者的临床特征及神经心理学评分。方法收集患者的一般人口学资料(包括性别、年龄、教育程度、病程)并行简易精神状态量表(MMSE)、日常生活能力量表(ADL)、言语流畅性试验(VFT)和画钟试验(CDT)等检查。所有病例(173例),包括阿尔茨海默病(AD)132例和轻度认知功能损害(MCI)41例,均按照临床痴呆评定量表(CDR)评定认知功能损害的严重程度。结果 173例患者中女107例,男66例,(女∶男=1.62∶1);四组间患者的年龄、教育程度、病程及MMSE、ADL、CDT、VFT分值经分析差异有统计学意义(P<0.05)。结论年龄大、教育程度低、病程长的患者认知功能损害重。不同程度的认知损害患者,其神经心理学评分存在显著差异。 Objective To compare clinical characteristics and neuropsychological test scores among different degrees of patients with cognitive impairment.Methods Patient demographic data(including sex,age,education and course of disease) were collected and patients were tested with MMSE(Mini-Mental State Examination),ADL(Activities of Daily Living),VFT(Verbal Fluency Test) and CDT(Clock Drawing Test) .Degree of cognitive impairment(n = 173,including AD = 132 and MCI = 41) was evaluated according to CDR(Clinical Dementia Rating) .Results All 173 patients(107 females and 66 males,female:male =1.62∶ 1) were involved in the analysis.There were significant differences in age,education,course of disease and scores of MMSE,ADL,CDT,VFT among four groups.Conclusions Elder patients with less education and longer course of disease have severe cognitive impairment.Different degrees of patients with cognitive impairment have significant differences in neuropsychological test scores.
作者 王智樱 陈刚
出处 《中华临床医师杂志(电子版)》 CAS 2010年第8期10-13,共4页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献10

  • 1张振馨,Zahner GE,Roman GC,刘君,洪震,屈秋民,刘协和,张晓君,周玢,武成斌,唐牟尼,洪霞,李辉.中国北京、西安、上海和成都地区痴呆亚型患病率的研究[J].中国现代神经疾病杂志,2005,5(3):156-157. 被引量:115
  • 2McKhann G,Drachman D,Folstein M,et al.Clinical diagnosis of Alzheimer′s disease:Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer′s Disease.Neurology,1984,34(7):939-944.
  • 3Peterson RC,Doody R,Kurz A,et al.Current conception mild cognitive impairment.Arch Neurol,2001,58(12):1985-1992.
  • 4World Health Organization(WHO).The neurological adaptation of the international classification of disease (ICD-10).Geneva:World Health Organization,1991.
  • 5Chen JH,Lin KP,Chen YC.Risk factors for dementia.J Formos Med Assoc,2009,108(10):754-764.
  • 6Launer LJ,Masaki K,Petrovitch H,et al.The association between midlife blood pressure levels and late-life cognitive function.The Honolulu-Asia Aging study.JAMA,1995,274(23):1846-1851.
  • 7Musicco M.Gender differences in the occurrence of Alzheimer′s disease.Funct Neurol,2009,24(2):89-92.
  • 8Depp CA,Jeste DV.Definitions and predictors of successful aging:a comprehensive review of larger quantitative studies.Am J Gefia Psychiatry,2006,14(1):6-20.
  • 9Scarmeas N,Albert SM,Manly JJ,et al.Education and rates of cognitive decline in incident Alzheimer′s disease.J Neurol Neurosurg Psychiatry,2006,77(3):308-316.
  • 10Ropacki SA,Jeste DV.Epidemiology of and Risk Factors for Psychosis of Alzheimer′s Disease:A Review of 55 Studies Published From 1990 to 2003.Am J Psychiatry,2005,162(11):2022-2030.

共引文献114

同被引文献19

  • 1毛秋粉,尹雅芙,刘浩,李娜,李雪娜,周久茂,李亚明.乳腺癌患者化疗后认知功能障碍的研究现状[J].中华临床医师杂志(电子版),2011,5(15):4462-4464. 被引量:8
  • 2Bauke Buwalda,Sanne B. Schagen.Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?[J].Life Sciences.2013
  • 3Jennifer Bruno,S.M. Hadi Hosseini,Shelli Kesler.Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors[J].Neurobiology of Disease.2012(3)
  • 4Amanda D. Hutchinson,Jessica R. Hosking,Ganessan Kichenadasse,Julie K. Mattiske,Carlene Wilson.Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review[J].Cancer Treatment Reviews.2012(7)
  • 5Yin Ting Cheung,Wai Keung Chui,Alexandre Chan.Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations[J].Critical Reviews in Oncology / Hematology.2011(1)
  • 6Diane Von Ah,Barbara Habermann,Janet S. Carpenter,Brandy L. Schneider.Impact of perceived cognitive impairment in breast cancer survivors[J].European Journal of Oncology Nursing.2012
  • 7Miyoung Yang,Joong-Sun Kim,Juhwan Kim,Sungwoong Jang,Sung-Ho Kim,Jong-Choon Kim,Taekyun Shin,Hongbing Wang,Changjong Moon.Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer[J].Brain Research Bulletin (-).2012(1-2)
  • 8Caroline H. Walker,Barbara A. Drew,James W. Antoon,Alan V. Kalueff,Barbara S. Beckman.Neurocognitive Effects of Chemotherapy and Endocrine Therapies in the Treatment of Breast Cancer: Recent Perspectives[J].Cancer Investigation.2012(2)
  • 9Yin Cheung,Earl Tan,Alexandre Chan.An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors[J].Supportive Care in Cancer.2012(7)
  • 10Edgar D.Staren,DigantGupta,Donald P.Braun.The Prognostic Role of Quality of Life Assessment in Breast Cancer[J].The Breast Journal.2011(6)

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部